Use of Intranasal Cromolyn Sodium for Allergic Rhinitis
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Allergic rhinitis affects 10% to 20% of Americans. It frequently coexists with other conditions, such as allergic conjunctivitis, sinusitis, and asthma, and is associated with impaired occupational function and performance in school, decreased quality of life, and increased health care costs. An efficacious agent with minimal adverse effects and a lack of drug interactions is needed to help simplify treatment of allergic rhinitis, especially in patients with comorbidities. Controlled studies of intranasal cromolyn sodium therapy for patients with seasonal and perennial allergic rhinitis are reviewed, and appropriate candidates for treatment with this agent are discussed. Cromolyn inhibits the degranulation of sensitized mast cells, thereby blocking the release of inflammatory and allergic mediators. It reduces symptoms of allergic rhinitis, and, when used prophylactically, cromolyn can prevent symptoms from occurring. Controlled studies comparing cromolyn with placebo, intranasal corticosteroids, and antihistamines have shown the efficacy of cromolyn in relieving rhinitis symptoms. In addition, because cromolyn is poorly absorbed systemically, it is well tolerated and not associated with drug interactions. Intranasal cromolyn has an excellent safety record, is available as an over-the-counter medication, and has been proved to be efficacious in patients with allergic rhinitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dykewicz, M. S., Fineman, S., Skoner, D. P., Nicklas, R., Lee, R., Blessing-Moore, J., Li, J. T., Bernstein, I. L., Berger, W., Spector, S., et al. (1998) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63155-9 · Cited by 652
Self-citationEpidemiology of Physician-Diagnosed Allergic Rhinitis in Childhood
Wright, A. L., Holberg, C. J., Halonen, M., Martinez, F. D., Morgan, W., & Taussig, L. M. (1994) · Pediatrics · doi:10.1542/peds.94.6.895 · Cited by 441
WELSH, P. W., STRICKER, W. E., CHU, C.-P., NAESSENS, J. M., REESE, M. E., REED, C. E., & MARCOUX, J. P. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61882-5 · Cited by 246
Effects of topical nasal treatment on asthma symptoms
Reed, C. E., Marcoux, J. P., & Welsh, P. W. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90177-7 · Cited by 67
Cited by
The diagnosis and management of rhinitis: An updated practice parameter
WALLACE, D., DYKEWICZ, M., BERNSTEIN, D., BLESSINGMOORE, J., COX, L., KHAN, D., LANG, D., NICKLAS, R., OPPENHEIMER, J., & PORTNOY, J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.06.003 · Cited by 1,096
“Patient selection is critical, and published review articles describe its limited role in treating and preventing allergic rhinitis symptoms.(947) There is no evidence that intranasal cromolyn will benefit patients with (1) vasomotor rhinitis, (2) NARES, or (3) nasal polyposis.”
BackgroundRhinitis 2020: A practice parameter update
Dykewicz, M. S., Wallace, D. V., Amrol, D. J., Baroody, F. M., Bernstein, J. A., Craig, T. J., Dinakar, C., Ellis, A. K., Finegold, I., Golden, D. B. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.007 · Cited by 436
Self-citationBSACI guidelines for the management of allergic and non‐allergic rhinitis
Scadding, G. K., Durham, S. R., Mirakian, R., Jones, N. S., Leech, S. C., Farooque, S., Ryan, D., Walker, S. M., Clark, A. T., Dixon, T. A., et al. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02888.x · Cited by 375
Scadding, G. K., Kariyawasam, H. H., Scadding, G., Mirakian, R., Buckley, R. J., Dixon, T., Durham, S. R., Farooque, S., Jones, N., Leech, S., et al. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12953 · Cited by 359
Economic impact and quality-of-life burden of allergic rhinitis
Schoenwetter, W. F., Dupclay, L., Appajosyula, S., Botteman, M. F., & Pashos, C. L. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125003053 · Cited by 256
Metadata
- Authors
- Ratner, P. H., Ehrlich, P. M., Fineman, S. M., Meltzer, E. O., & Skoner, D. P.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 77
- Issue
- 4
- Pages
- 350-354
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W1978578175
- Cited by
- 70
- References
- 4
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Intranasal Cromolyn Sodium for Allergic Rhinitis. https://app.cochat.ai/papers/10.4065/77.4.350
- The paper
- Ratner, P. H., Ehrlich, P. M., Fineman, S. M., Meltzer, E. O., & Skoner, D. P. (2002). Use of Intranasal Cromolyn Sodium for Allergic Rhinitis. Mayo Clinic Proceedings. https://doi.org/10.4065/77.4.350
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.